Epilepsy and Alzheimer's cell therapy biotech lays off 25% of staff
A Bay Area biotech working on off-the-shelf cell therapies for epilepsy, Alzheimer’s and other undisclosed indications laid off about 25% of its workforce recently, Neurona …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
